3D blood test for advanced head and neck cancer
Part of Cancer clinical trials.
This study uses a special 3D culture method to grow and analyze tumor cells from the blood of people with advanced head and neck cancer. It also includes healthy volunteers for comparison, to help researchers understand how these cells behave and improve future detection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must agree to a blood draw and follow the study steps
- If you have cancer, it must be head and neck cancer that has spread (metastatic HNSCC)
- If you are a healthy volunteer, you must have had no cancer in the last 5 years
- Healthy volunteers cannot have any serious medical conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new immune cell therapy (GT201) combined with a PD-1 inhibitor for advanced head and neck cancer. It aims to see if your own immune cells, collected from your tumor, can be boosted to fight the cancer.
This trial is testing a new blood test (called a liquid biopsy) to better understand and predict the course of head and neck cancers that have come back or spread. If you join, researchers will use a special chip to look at your immune cells and tumor cells in your blood.
This trial studies whether detecting circulating tumor cells in the blood after chemoradiation can help predict outcomes for people with oral cancer that has spread to lymph nodes. It may help doctors better monitor the disease.
This trial uses a patient's own tumor cells grown in a lab to test which drugs are most likely to work against their cancer. It aims to help guide treatment choices for people with head and neck cancer that has come back or spread.
This study collects tissue from people with newly diagnosed head and neck squamous cell cancer and grows “mini tumor models” in the lab. The goal is to see how these models respond to new therapies, which may help guide more effective treatment choices in the future.
This study looks for early “biomarkers” (signals in blood or tissue) to see how well head and neck cancer treatments are working over time. It may help doctors adjust treatment sooner based on those early signals.
Hear when a new Circulating Tumor Cell trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.